ACS provides multiple resources to help people go from Cannabis 101 to understanding the latest cannabis research. Our courses provide useful education for the following groups:
Health Care Professionals With nearly a dozen courses to choose from, and more on the way, we offer health care professionals the opportunity to learn about the comprehensive world of cannabis as medicine. |
|
Cannabis Industry Professionals We offer a specialized course for budtenders and patient advocates to help those professionals better serve their medical cannabis community. We also offer courses that explore the many compounds in cannabis and the role they play in cannabis consumption. |
|
Regulators and Lawmakers These professionals play a pivotal role in cannabis legislation and regulation in numerous government bodies. Our mission is to inform the decisions these authorities make with human-based science and expert experience. Our courses offer both of these, with expert instructors and the science to back it up. |
Introduction to Cannabinoid Medicine CME Course This 3-hour CME AMA PRA Category 1 Credit™ enduring video presentation covers Endocannabinoid System in humans, basic chemistry of cannabinoid medications, delivery systems, and more. At the end of this course, there is a CME accreditation examination. |
Customer/Patient Service Advocate (Budtender) Training Course This course is intended to train Patient Service Advocates (aka Budtenders) with special emphasis on professionalism, patient care, and interacting with clinicians. |
Cannabis in Obstetrics and Gynecology Becky Lynn, MD, talks about issues related to female health and the use of cannabis and cannabinoids. |
Cannabinoids in Gastroenterology (GI) Adam Abodeely, MD, discusses the use of cannabis and cannabinoids to treat a wide array of GI illnesses. |
Secondary Compounds in Cannabis Jahan Marcu, Ph.D., discussed secondary or alternative compounds from cannabis, what we know about them, and how they might be useful. |
Minchul An, Pharm.D., discusses a wide range of drug interactions and the biochemistry of cannabinoids. |
Minor Cannabinoids: What Do We Really Know? This course will discuss the current scientific literature on a range of common minor cannabinoids and present analysis of where this literature stands in the process leading to treatments for Human beings. |
Terpenes: The State of the Data This course will discuss the current scientific literature on a range of common terpenes and present analysis of where this literature stands in the process leading to treatments for Human beings. |
The Dark Side of CBD: Conversion to Other Cannabinoids This course will discuss the conversion of CBD, derived from hemp, into delta-8 THC, HHC, and others, that are being sold currently. It will describe how the chemistry involved can lead to byproducts that may be dangerous and not readily detectible. |
Approach to Cannabis and Anesthesia This course will discuss the conversion of cannabis and various cannabinoids on anesthesia, in general and by organ system, and provide human evidence based guidance on how to approach advising cannabis patients in the peri-operative period. |